CD274 and metastatic neoplasm: This cohort study analyzes the association of metastatic disease pattern with response to programmed cell death receptor 1/programmed cell death ligand 1–targeting therapy in patients with treatment-resistant microsatellite stable metastatic colorectal cancer.